Function
Processes
Locations
Preferentially activates long-chain PUFAs; loss of ACSL4 depletes PUFA-phospholipids and confers ferroptosis resistance, making ACSL4 a pro-ferroptotic driver.
A decomposition of ferroptosis: the iron-dependent form of regulated cell death in which polyunsaturated-fatty-acid (PUFA) phospholipids in cellular membranes undergo iron-catalysed peroxidation to lipid hydroperoxides, ultimately rupturing the membrane. Ferroptosis is morphologically and biochemically distinct from apoptosis, necroptosis, and pyroptosis: there is no caspase cascade and no dedicated executioner enzyme. Instead the program is defined by the balance between (a) a driver arm that supplies the oxidisable substrate (PUFA phospholipids) and the redox-active iron that catalyses peroxidation, and (b) several biochemically independent defense arms that detoxify lipid hydroperoxides or quench the propagating radicals. Death occurs when the defenses are overwhelmed, so ferroptosis is best modelled as one execution node negatively regulated, in parallel and redundantly, by multiple suppressor systems. Design intent: the module is organized as a driver layer (PUFA-phospholipid supply and labile-iron supply) that provides input to a central execution node (GO:0097707 ferroptosis), opposed by four independent suppressor sub-modules that each NEGATIVELY_REGULATE the execution node: the canonical GPX4-glutathione axis, the FSP1-CoQ10 axis, the mitochondrial DHODH-CoQ10 axis, and the GCH1-BH4 (tetrahydrobiopterin) axis. A transcriptional/regulatory sub-module (NRF2/KEAP1, ATF4, p53) tunes the set point of these defenses and is kept optional. The module is framed for the human/mammalian implementation, where ferroptosis was defined, but the core chemistry (iron + O2 + PUFA membranes) and the principal defenses (GPX4, the CoQ system) are deeply conserved across eukaryotes, with ferroptosis-like death reported in plants, fungi, and protozoa. Genes are grounded to UniProt and GO ids taken from the matching per-gene reviews under genes/human/; GO ids are used only in their correct aspect (MF in function, BP in processes/concepts, CC in locations).
Ferroptosis has no single linear execution effector, which is the key contrast with cuproptosis: the interesting structure is several biochemically independent suppressor arms (GPX4-GSH, FSP1-CoQ, DHODH-CoQ, GCH1-BH4) acting as redundant NEGATIVELY_REGULATES edges onto one execution node, so loss of any single arm is buffered by the others. The execution node is modelled as a process-level effect (GO:0097707) with an ANY_PARTICIPANT annoton rather than a distinct MF, because the lethal event is radical-chain lipid peroxidation and membrane rupture, for which there is no exact GO molecular function. Iron handling and PUFA-phospholipid biosynthesis are upstream physiology that set the death threshold: NCOA4-driven ferritinophagy and TFRC import raise the labile-iron pool (pro-ferroptotic), while FTH1 storage and SLC40A1 export lower it (protective). p53 (TP53) is included as a context-dependent regulator that is pro-ferroptotic in the canonical SLC7A11-repression context. Scope boundaries: general fatty-acid/phospholipid metabolism (FADS1/2, ELOVL5, LPCAT3's housekeeping remodelling), general glutathione and one-carbon metabolism, and the broader NRF2 antioxidant program are adjacent and are treated here only insofar as they supply substrate to, or gate, ferroptosis.
All recommended fields populated.
✗ none found
No MODULE:ferroptosis deep-research report alongside the module YAML.
1 leaf node(s) with no concrete protein grounding:
6 conformance issue(s):
16 complete review(s) · 20 with deep research · 3 missing review · 1 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| ACSL4 O60488 | ✓ | ✓ | ✓ |
| AIFM2 Q9BRQ8 | ✓ | ✓ | ✓ |
| ATF4 P18848 | ✓ | 215/216 | ✓ |
| DHODH Q02127 | ✓ | ✓ | ✓ |
| FTH1 P02794 | ✓ | ✓ | ✓ |
| GCH1 P30793 | ✓ | 69/70 | ✓ |
| GCLC P48506 | ✓ | ✓ | ✓ |
| GPX4 P36969 | ✓ | 52/55 | ✓ |
| GSS P48637 | ✓ | ✓ | ✓ |
| KCTD10 Q9H3F6 | ✓ | ✓ | ✗ |
| KEAP1 Q14145 | ✓ | ✓ | ✓ |
| LPCAT3 Q6P1A2 | ✓ | 66/72 | ✓ |
| NCOA4 Q13772 | ✓ | 23/25 | ✓ |
| NFE2L2 Q16236 | ✓ | ✓ | ✓ |
| LAMP2 (LAMP2A) P13473 | ✗ | — | — |
| PTS Q03393 | ✓ | ✓ | ✓ |
| EGLN3 (PHD3) Q9H6Z9 | ✗ | — | — |
| USP18 Q9UMW8 | ✗ | — | — |
| SLC3A2 P08195 | ✓ | ✓ | ✓ |
| SLC40A1 Q9NP59 | ✓ | ✓ | ✓ |
| SLC7A11 Q9UPY5 | ✓ | ✓ | ✓ |
| SPR P35270 | ✓ | ✓ | ✓ |
| TFRC P02786 | ✓ | ✓ | ✓ |
| TP53 P04637 | ✓ | ✓ | ✓ |
Esterification of polyunsaturated fatty acids into membrane phospholipids generates the bis-allylic substrate that is peroxidised during ferroptosis. ACSL4 activates PUFAs as acyl-CoAs and LPCAT3 inserts them into phospholipids; cells enriched in PUFA-PLs are ferroptosis-sensitive. FADS1/FADS2 and ELOVL5 (reviewed in the project) feed the upstream PUFA pool.
Preferentially activates long-chain PUFAs; loss of ACSL4 depletes PUFA-phospholipids and confers ferroptosis resistance, making ACSL4 a pro-ferroptotic driver.
Re-acylates lysophospholipids with PUFA-CoA, installing the oxidisable PUFA chains (esp. in phosphatidylethanolamine) that are the peroxidation substrate; cooperates with ACSL4 as a driver.
Redox-active Fe(II) catalyses lipid-radical generation (Fenton chemistry) and is a cofactor of lipoxygenases. Import (TFRC) and ferritinophagy (NCOA4) raise the labile-iron pool and sensitize cells; ferritin storage (FTH1) and export (SLC40A1) lower it and protect.
Principal route of transferrin-bound iron uptake; higher import raises the labile-iron pool and ferroptosis sensitivity (TFRC is also used as a ferroptosis marker).
Selective autophagy receptor that delivers ferritin to the lysosome; ferritinophagy releases stored iron into the labile pool, a pro-ferroptotic input.
Ferroxidase subunit of the ferritin complex that sequesters iron in a redox-inert form, lowering the labile-iron pool; protective against ferroptosis (and a NCOA4 substrate).
The only known cellular iron exporter; export lowers intracellular iron and is protective against ferroptosis.
Iron-catalysed (enzymatic via lipoxygenases/POR and non-enzymatic autoxidative) peroxidation of PUFA-phospholipids generates lipid hydroperoxides; when these outrun the suppressor arms, propagating radicals and reactive breakdown products destabilize and rupture the membrane, killing the cell.
Integrates PUFA-PL peroxidation and iron-catalysed radical propagation into membrane-rupturing cell death; the node that every suppressor arm negatively regulates.
The classical ferroptosis-suppressing axis: system xc- (SLC7A11/SLC3A2) imports cystine for glutathione synthesis (GCLC then GSS), and GPX4 uses glutathione to reduce phospholipid hydroperoxides to non-reactive alcohols. GPX4 is the central suppressor node.
Imports cystine in exchange for glutamate, supplying cysteine for glutathione synthesis; the rate-limiting input to the GPX4 axis and the target of erastin and of p53-mediated repression.
Obligate heavy-chain partner that traffics and stabilizes SLC7A11 at the plasma membrane; required for system xc- function.
Catalyses the rate-limiting step of glutathione biosynthesis (gamma-glutamylcysteine formation); supplies the GPX4 cofactor.
Completes glutathione synthesis from gamma-glutamylcysteine and glycine; provides the reducing cofactor for GPX4.
The central ferroptosis suppressor: directly reduces phospholipid hydroperoxides to alcohols using glutathione, defusing the lethal substrate. GPX4 inhibition (e.g. RSL3) is the canonical way to trigger ferroptosis.
A glutathione/GPX4-independent suppressor axis: FSP1 (AIFM2) reduces ubiquinone (CoQ10) to ubiquinol, a lipophilic radical-trapping antioxidant that halts lipid-peroxidation chain propagation at the membrane. Parallel to and redundant with GPX4.
Myristoylation-targeted NAD(P)H:ubiquinone oxidoreductase that regenerates ubiquinol at membranes to trap lipid radicals, suppressing ferroptosis independently of glutathione/GPX4.
The mitochondrial inner-membrane arm of CoQ-based defense: DHODH reduces CoQ to ubiquinol in the inner membrane (coupled to its role in de novo pyrimidine synthesis), counteracting mitochondrial lipid peroxidation in parallel with mitochondrial GPX4.
Reduces CoQ to ubiquinol at the mitochondrial inner membrane; proposed to defend mitochondrial membranes against lipid peroxidation in parallel with GPX4, especially where GPX4 is low.
GTP cyclohydrolase I (GCH1) is rate-limiting for biosynthesis of tetrahydrobiopterin (BH4), a lipophilic radical-trapping antioxidant that protects membrane PUFAs (and helps regenerate CoQ); PTS and SPR complete BH4 synthesis. A third independent suppressor axis.
Rate-limiting enzyme of BH4 synthesis; GCH1/BH4 levels set ferroptosis resistance by supplying a radical-trapping antioxidant that protects PUFA-phospholipids.
Second enzyme of de novo BH4 synthesis, downstream of GCH1.
Catalyses the final step of de novo BH4 synthesis, completing the antioxidant supply of the GCH1-BH4 axis.
Transcriptional set-point controllers of the defense arms: NRF2 (NFE2L2) induces SLC7A11, GPX4, GCLC, FTH1, and FSP1; KEAP1 represses NRF2; ATF4 (integrated stress response) induces SLC7A11; p53 (TP53) is context-dependent and, in the canonical context, represses SLC7A11 to promote ferroptosis.
Master antioxidant-response transcription factor; induces multiple ferroptosis defenses (system xc-, GPX4, glutathione synthesis, ferritin, FSP1), so a positive regulator of the suppressor arms.
CUL3 substrate adaptor that targets NRF2 for degradation under basal conditions; by repressing NRF2 it lowers defense expression and is permissive for ferroptosis.
Integrated-stress-response transcription factor that induces SLC7A11 and other adaptive genes; generally a positive regulator of the GPX4 axis (cysteine supply).
Context-dependent regulator; canonically pro-ferroptotic by transcriptionally repressing SLC7A11 (and via SAT1/ALOX), though it can be anti-ferroptotic in other contexts. Modelled here as a negative regulator of the GPX4 axis.
Post-translational set-point control of the two principal defense factors, abstracted from curated GO-CAMs. Each child realization embeds the ferroptosis_defense_factor_switch motif (an opposed destabilizer/stabilizer pair acting on one suppressor) via conforms_to, and is grounded to the production GO-CAM(s) that realize it.
GPX4 abundance is lowered by chaperone-mediated autophagy (HSPA8/LAMP2A) and preserved by EGLN3/PHD3 prolyl hydroxylation, which masks GPX4 from CMA recognition.
The regulated defense factor.
CMA delivers GPX4 for lysosomal degradation, lowering it.
Hydroxylates GPX4, masking it from CMA and stabilizing it.
SLC7A11 abundance is lowered by a CUL3-KCTD10-RBX1 (CRL3) ubiquitin ligase and restored by the deubiquitinase USP18.
The regulated defense factor.
CRL3 ubiquitinates SLC7A11 for degradation, lowering it.
Removes ubiquitin from SLC7A11 to stabilize it (MF flagged UNCERTAIN in the GO-CAM review: USP18 is canonically ISG15-specific).